Swedbank AB boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 18.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 192,504 shares of the company's stock after buying an additional 29,420 shares during the quarter. Swedbank AB owned 0.16% of Clorox worth $23,114,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the business. Vanguard Group Inc. boosted its holdings in Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock valued at $2,293,135,000 after purchasing an additional 65,924 shares during the period. Northern Trust Corp raised its position in Clorox by 2.3% in the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock valued at $225,133,000 after purchasing an additional 34,655 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Clorox by 7.4% in the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock valued at $200,512,000 after buying an additional 94,371 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company's stock worth $170,406,000 after buying an additional 41,485 shares in the last quarter. Finally, Hsbc Holdings PLC increased its stake in shares of Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after buying an additional 589,544 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.
Clorox Price Performance
Shares of CLX traded down $0.29 during trading hours on Tuesday, reaching $119.64. The company had a trading volume of 762,342 shares, compared to its average volume of 1,680,869. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37. The firm has a 50 day simple moving average of $123.89 and a 200-day simple moving average of $130.93. The company has a market capitalization of $14.63 billion, a price-to-earnings ratio of 18.35, a PEG ratio of 0.98 and a beta of 0.52.
Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same period in the prior year, the business posted $1.82 earnings per share. The firm's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox's payout ratio is presently 76.07%.
Insiders Place Their Bets
In other news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.57% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on CLX. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research note on Monday, September 8th. Barclays decreased their price objective on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Jefferies Financial Group lowered their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. UBS Group dropped their target price on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Finally, Citigroup reaffirmed a "neutral" rating and set a $135.00 price target (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Reduce" and an average price target of $142.18.
Check Out Our Latest Analysis on CLX
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report